Ila A. Davis and BarryT. Rouse.

Department of Microbiology, University of Tennessee, Knoxville, Tennessee, 37996

Received 11/25/ 97 Accepted 11/28/97

6. REFERENCES

1. Burnet Sir FM: RM: Immunological Surveillance. Elsevier Science, New York, New York. (1970)

2. Zinkernagel RM: Immunology taught by viruses: Science 271, 173-178 (1996)

3. Rouse BT: Pathogenesis of the herpesviruses. Lab An Sci 43(1), 11-14 (1993)

4. Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9, 24-34 (1997)

5. Bukowski JF, B.A. Woda and R.M. Welsh: Pathogenesis of murine cytomegalovirus in natural killer cell-depleted mice. J Virol 52, 119-128 (1984)

6. Farrell HE, H. Vally, D.M. Lynch, P. Flemming, G.R. Shellam, A.A. Scalzo and N.J. Davis-Poynter: Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386, 510-514 (1997)

7. Reyburn HT, O. Mandelboim, M. Vales-Gomez, D.M. Davis, L. Pazmany and J.L. Strominger: The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386, 514-517 (1997)

8. Biron CA: Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 6, 530-538 (1994)

9. Niemialtowski MG, F.N. Toka, E. Malicka, I. Spohr de Faunfez, M. Gierynska and A. Schollenberger: Orthopoxviruses and their immune escape. Rev Med Virol 7, 35-47 (1997)

10. Chang HW, J.C. Watson and B.L. Jacobs: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 89, 4825-4829 (1992)

11. Symons JA, A. Alcami and G.L. Smith: Vaccinia virus encodes a soluble type 1 interferon receptor of novel structure and broad species specificity. Cell 81, 551-560 (1995)

12. Alcami A. and G. L. Smith: A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167 (1992)

13. Upton C, K. Mossman and G. McFadden: Encoding of a homolog of the IFN-gamma receptor of myxoma virus. Science 258, 1369-1372 (1992)

14. Moore PS, C. Boshoff, R. A. Weiss and Y. Chang: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744 (1996)

15. Albrecht J-C and B. Fleckenstein: New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 66(6), 3937-3940 (1992)

16. Rother RP, S.A. Rollins, W.L. Fodor, J-C Albrecht, E. Setter, B. Fleckenstein and S.P. Squinto: Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68(2), 730-737 (1994)

17. Friedman HM, L. Wang, N.O. Fishman, J.D. Lambris, R.J. Eisenberg, G.H. Cohen and J. Lubinski: Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol 70(7), 4235-4260 (1996)

18. Hidaka Y, Y. Toh and R. Mori: gC of HSV-1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of infected cells. J Gen Virol 72, 915-921 (1991)

19. McMichael A.J. and R.E. Phillips: Escape of human immunodeficiency virus from immune control. Ann Rev Immunol 15, 271-296 (1997)

20. Webster RG, W.G. Laver, G.M. Air and G.C. Schild: Molecular mechanisms of variation in influenza viruses. Nature 296, 115-121 (1982)

21. Zinkernagel RM: Virus induced immunopathology. In: Viral Pathogenesis. Eds: N. Nathanson, R. Ahmed, F. Gonzales-Scarano, D.E. Griffin, K.V. Holmes, F.A. Murphy and H.L. Robinson. Lippincott-Raven Press, Philadelphia. 163-179 (1997)

22. Doherty P.C. and R. Ahmed: Immune responses to viral infection. In: Viral Pathogenesis. Eds: N. Nathanson, R. Ahmed, F. Gonzales-Scarano, D.E. Griffin, K.V. Holmes, F.A. Murphy and H.L. Robinson. Lippincott-Raven Press, Philadelphia. 143-161 (1997)

23. Yasukawa M. and J.M. Zarling: Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J Immunol 133 (1), 422-427 (1984)

24. Tomazin R. A.B. Hill, P. Jugovic, I. York, P. van Endert, H.L. Ploegh, D.W. Andrews and D.C. Johnson: Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15(13), 3256-3266 (1996)

25. Jones T.R. and L. Sun: Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol 71(4), 2970-2979 (1997)

26. Ahn K, A. Angulo, P. Ghazall, P.A. Peterson, Y. Yang and K. Fruh: Human cytomegalovirus inhibits antigen presentation by a sequential multi-step process. Proc natl Acad Sci USA 93, 10990-10995 (1996)

27. Ahn K, A. Gruhler, B. Galocha, T.R. Jones, E.J.H.J. Wiertz, H.L. Pleogh, P.A. Peterson, Y. Yang and K. Fruh: The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6, 613-621 (1997)

28. Hengel H, J-O Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G.J. Hammerling, U.H. Koszinowski and F. Momburg: A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623-632 (1991)

29. Ziegler H, R. Thale, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson and U.H. Koszinowski: A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-golgi compartments. Immunity 6, 57-66 (1997)

30. Kleijnen M, J.B. Huppa, S. Mukerjee, H. Farrell, A. Campbell, U.H. Koszinowski, A.B. Hill and H.L. Pleogh: A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but transported to the cell surface. EMBO J 16, 685-694 (1997)

31. Posavad CM, D.M. Koelle and L. Corey: High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J Virol 70(11), 8165-8168 (1996)

32. Rinaldo CR: Immune suppression by herpes viruses. Annu Rev Med 41, 331-338 (1990)

33. Horowitz MS: Adenoviridae and their replication. In: Fields Virology, Second edition. Eds: B.N. Fields, D.M. Knipe, R. M. Chanock, M.S. Hirsch, J.L. Melnick, T.P. Monath and B. Roizman. Raven Press, New York, New York. 2, 1679-1722 (1990)

34. Burgert, H-G, J.L. Maryanski and S. Kvist: "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc natl Acad Sci USA 84, 1356-1360 (1987)

35. Pircher H, D Moskophidis, U. Rohrer, K. Burki, H. Hengartner and R.M. Zinkernagel: Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346, 629-633 (1990)

36. Phillips RE, S. Rowland-Jones, D.F. Nixon, F.M. Gotch, J.P. Edwards, A.O. Ogunlesi, J.G. Elvin, J.A. Rothbard, C.R.M. Angham, C.R. Rizza and A.J. McMichael: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459 (1991)

37. McMichael A.J. and R.E. Phillips: Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 15, 271-296 (1997)

38. Levitskaya J, M. Coram, V. Levitsky, S. Imreh, P.M. Steigerwald-Mullen, G. Klein, M.G. Kurilla and M.G. Masucci: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1. Nature 375, 685-688 (1995)

39. De Campos-Lima P-O, V. Levitsky, J. Brooks, S.P. Lee, L.F. Hu, A.B. Rickinson and M.G. Masucci: T cell responses and viral evolution: Loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med 179, 1297-1305 (1994)

40. De Campos-Lima P-O, V. Vevitsky, M.P. Imreh, R. Gavioli and M.G. Masucci: Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J Exp Med 186(1), 83-89 (1997)

41. Gregory CD, R.J. Murray, C.F. Edwards and A.B. Rickinson: Down regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumour cell escape from virus-specific T cell surveillance. J Exp Med 167, 1811-1824 (1988)

42. Teodoro J.G. and P.E. Branton: Regulation of apoptosis by viral gene products. J Virol 71(3), 1739-1746 (1997)

43. Wold WSM, A.E. Tollefson and T.W. Hermiston: Strategies of immune modulation by adenoviruses. In: Viroceptors, virokines and related immune modulators encoded by DNA viruses. Ed: G. McFadden. R.G. Landes, Georgetown, Texas. 147-185 (1995)

44. Thome M, P. Schneider, K. Hoffman, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J-L Bodmer, M. Schroter, C. Scaffidi, P.H. Krammer, M.E. Peters and J. Tschopp: Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521 (1997)

45. Gagliardini V, P-A Fernandez, R.K.K. Lee, H.C.A. Drexler, R.J. Rotello, M.C. Fishman and J Yuan: Prevention of vertebrate neuronal death by the crmA gene. Science 263, 826-828 (1994)

46. Henderson S, M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff and A. Rickinson: Induction of bcl-2 expression by Epstein-Barr virus latant membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115 (1991)

47. Henderson S, D. Huen, M. Rowe, C. Dawson, G. Johnson and A. Rickinson: Epstein-Barr virus encoded BHRF1 protein, a viral homologue of bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90, 8479-8483 (1991)

48. Szekely L, G. Selivanova, K.P. Magnusson, G. Klein and K.G. Wiman: EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90, 5455-5459 (1993)

49. Zhang Q, D. Gutsch and S. Kenney: Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 14, 1929-1938 (1994)

50. Koyama A.H. and Y. Miwa: Suppression of apoptotic DNA fragmentation in herpes simplex virus type-1 infected cells. J Virol 71(3), 2567-2571 (1997)

51. Chou J, A.P.W. Poon, J. Johnson and B. Roizman: Association of a Mr 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 1-34.5 mutants of herpes simplex virus 1. Proc Natl Acad Sci USA 92, 10516-10520 (1995)

52. Matloubian M, R.J. Concepcion and R. Ahmed: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68(12), 8056-8063 (1994)

53. Lewandowski GA, D. Lo and F.E. Bloom: Interference with major histocompatibility complex class-II restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. Proc Natl Acad Sci USA 90, 2005-2009 (1993)

54. Lewandowski G, M.V. Hobbs and F.E. Bloom: Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunology 55, 23-34 (1994)

55. Mester J.C. and B.T. Rouse: The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis 13(11), S935-945 (1991)

56. Li Z, S.M. Turk and L.M. Hutt-Fletcher: The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 69, 3987-3994 (1995)

57. Lindahl P, I. Gesser, P. Leary and M.G. Tovey: Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci USA 73, 1284-1287 (1976)

58. Hsu, D-H, R. de Waal-Malefyt, D.F. Fiorentino, M-N Dang, P. Vieira, J. de Vries, H. Spits, T.R. Mosmann and K.W. Moore: Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250, 830-832 (1990)

59. Mosmann T.R. and R.L. Coffman: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7, 145-173 (1989)

60. Miller CL, J.H. Lee, E. Kieff and R. Longnecker: An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin cross-linking. Proc Natl Acad Sci USA 91, 772-776 (1994)

61. Spriggs MK: One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 14, 101-130 (1996)

62. Janaswami PM, D.V.R. Kalvakolanu, Y. Zhang and G.C. Se: Adenovirus E1A gene product suppresses transcription of IL-6 gene by interacting at the IL-6 promoter. J Biol Chem 267(34), 24886-24891 (1992)

63. Ruzek MC, A.H. Miller, S.M. Opal, B.D. Pearce and C.A. Biron: Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 185(7), 1185-1192 (1997)

64. Johnson DC, M.C. Frame, M.W. Ligas, A.M. Cross and N.D. Stow: Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62(4), 1347-1354 (1988)

65. Dubin G, E. Socolof, I. Frank and H.M. Friedman: Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol 65(12), 7046-7050 (1991)

66. Dingwell KS, C.R. Brunetti, R.L. Hendricks, Q. Tang, M. Tang, A.J. Rainbow and D.C. Johnson: Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol 68(2), 834-845 (1994)